Silk Road Medical Past Earnings Performance
Past criteria checks 0/6
Silk Road Medical's earnings have been declining at an average annual rate of -3.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 28% per year.
Key information
-3.5%
Earnings growth rate
76.6%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 28.0% |
Return on equity | -36.9% |
Net Margin | -31.5% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story
Feb 03A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb
Dec 20Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Aug 05Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price
May 05Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Apr 04Silk Road Medical announces $100M common stock offering
Oct 17Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Sep 24Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M
Jul 26Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture
Jul 19Silk Road Medical falls after Citigroup downgrades to Sell from Neutral
Jul 11Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Jun 09Silk Road Medical - What A Road It Has Been
Apr 08Is Silk Road Medical (NASDAQ:SILK) Using Debt Sensibly?
Feb 23Silk Road Medical, Inc's (NASDAQ:SILK) Intrinsic Value Is Potentially 48% Above Its Share Price
Jan 24Is It Too Late To Consider Buying Silk Road Medical, Inc (NASDAQ:SILK)?
Dec 09Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 18Revenue & Expenses BreakdownBeta
How Silk Road Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 177 | -56 | 145 | 41 |
30 Sep 23 | 170 | -55 | 138 | 40 |
30 Jun 23 | 163 | -53 | 131 | 39 |
31 Mar 23 | 151 | -55 | 123 | 39 |
31 Dec 22 | 139 | -55 | 116 | 36 |
30 Sep 22 | 127 | -57 | 111 | 35 |
30 Jun 22 | 114 | -61 | 108 | 33 |
31 Mar 22 | 107 | -56 | 102 | 30 |
31 Dec 21 | 101 | -50 | 96 | 27 |
30 Sep 21 | 94 | -52 | 90 | 30 |
30 Jun 21 | 90 | -48 | 84 | 27 |
31 Mar 21 | 78 | -48 | 77 | 24 |
31 Dec 20 | 75 | -47 | 76 | 21 |
30 Sep 20 | 73 | -39 | 73 | 14 |
30 Jun 20 | 70 | -37 | 71 | 13 |
31 Mar 20 | 70 | -38 | 69 | 13 |
31 Dec 19 | 63 | -52 | 63 | 12 |
30 Sep 19 | 56 | -60 | 57 | 12 |
30 Jun 19 | 49 | -61 | 49 | 12 |
31 Mar 19 | 42 | -56 | 42 | 11 |
31 Dec 18 | 35 | -38 | 35 | 10 |
31 Dec 17 | 14 | -19 | 20 | 7 |
Quality Earnings: SILK is currently unprofitable.
Growing Profit Margin: SILK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SILK is unprofitable, and losses have increased over the past 5 years at a rate of 3.5% per year.
Accelerating Growth: Unable to compare SILK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SILK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.7%).
Return on Equity
High ROE: SILK has a negative Return on Equity (-36.88%), as it is currently unprofitable.